IntellxxDNA’s Innovative Memory and Genomics Decision-Making Tool Study Gains IRB Approval
Signifying a new era in cognitive health research, IntellxxDNA™ is proud to announce its IRB approval for the GPS-MEM Study: A Precision Study of Memory.
- Signifying a new era in cognitive health research, IntellxxDNA™ is proud to announce its IRB approval for the GPS-MEM Study: A Precision Study of Memory.
- The study will evaluate the efficacy of IntellxxDNA's clinical decision support (CDS) tool.
- The final goal is to gather feedback from medical practitioners on how significantly the IntellxxDNA™ genomics tool influenced and aided their decision-making process.
- The study obtained IRB approval on August 16, 2023, with Protocol Number INT-MEM-101 and Approval Number: IRCM-2023-376.